Karagiannis, Sophia N.

Myosin II Reactivation and Cytoskeletal Remodeling as a Hallmark and a Vulnerability in Melanoma Therapy Resistance

Orgaz, J. L., Crosas-Molist, E., Sadok, A., Perdrix-Rosell, A., Maiques, O., Rodriguez-Hernandez, I., Monger, J., Mele, S., Georgouli, M., Bridgeman, V., et al. (2020) · Cancer Cell

Melanoma and MAPK PathwaysCancer Immunotherapy and Biomarkers

Cited by 151

IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural states

Pellizzari, G., Hoskin, C., Crescioli, S., Mele, S., Gotovina, J., Chiaruttini, G., Bianchini, R., Ilieva, K., Bax, H. J., Papa, S., et al. (2019) · EBioMedicine

Immune cells in cancerMonoclonal and Polyclonal Antibodies Research

Cited by 77

IgE immunotherapy: A novel concept with promise for the treatment of cancer

Josephs, D. H., Spicer, J. F., Karagiannis, P., Gould, H. J., & Karagiannis, S. N. (2014) · mAbs

Monoclonal and Polyclonal Antibodies ResearchCancer Immunotherapy and Biomarkers

Cited by 58

Harnessing Therapeutic IgE Antibodies to Re-educate Macrophages against Cancer

Pellizzari, G., Bax, H. J., Josephs, D. H., Gotovina, J., Jensen-Jarolim, E., Spicer, J. F., & Karagiannis, S. N. (2020) · Trends in Molecular Medicine

Immune cells in cancerMonoclonal and Polyclonal Antibodies Research

Cited by 29